[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Metformin Hydrochloride-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

March 2018 | 147 pages | ID: M6F7F2D71D5MEN
MIReports Co., Limited

US$ 3,680.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Metformin Hydrochloride-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Metformin Hydrochloride industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Metformin Hydrochloride 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Metformin Hydrochloride worldwide and market share by regions, with company and product introduction, position in the Metformin Hydrochloride market
Market status and development trend of Metformin Hydrochloride by types and applications
Cost and profit status of Metformin Hydrochloride, and marketing status
Market growth drivers and challenges

The report segments the global Metformin Hydrochloride market as:

Global Metformin Hydrochloride Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Metformin Hydrochloride Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Metformin HCL
Metformin DC
Others

Global Metformin Hydrochloride Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others Form

Global Metformin Hydrochloride Market: Manufacturers Segment Analysis (Company and Product introduction, Metformin Hydrochloride Sales Volume, Revenue, Price and Gross Margin):

Bristol-Mayers Squibb
Shouguang Fukang Pharmaceutical
Harman Finochem
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
FARMHISPANIA GROUP
Shijiazhuang Polee Pharmaceutical
Merck Sante
Aarti Drugs
TEVA
Taj API
Wanbury

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF METFORMIN HYDROCHLORIDE

1.1 Definition of Metformin Hydrochloride in This Report
1.2 Commercial Types of Metformin Hydrochloride
  1.2.1 Metformin HCL
  1.2.2 Metformin DC
  1.2.3 Others
1.3 Downstream Application of Metformin Hydrochloride
  1.3.1 Metformin Hydrochloride Tablets
  1.3.2 Metformin Hydrochloride Extended-Release Tablets
  1.3.3 Others Form
1.4 Development History of Metformin Hydrochloride
1.5 Market Status and Trend of Metformin Hydrochloride 2013-2023
  1.5.1 Global Metformin Hydrochloride Market Status and Trend 2013-2023
  1.5.2 Regional Metformin Hydrochloride Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Metformin Hydrochloride 2013-2017
2.2 Sales Market of Metformin Hydrochloride by Regions
  2.2.1 Sales Volume of Metformin Hydrochloride by Regions
  2.2.2 Sales Value of Metformin Hydrochloride by Regions
2.3 Production Market of Metformin Hydrochloride by Regions
2.4 Global Market Forecast of Metformin Hydrochloride 2018-2023
  2.4.1 Global Market Forecast of Metformin Hydrochloride 2018-2023
  2.4.2 Market Forecast of Metformin Hydrochloride by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Metformin Hydrochloride by Types
3.2 Sales Value of Metformin Hydrochloride by Types
3.3 Market Forecast of Metformin Hydrochloride by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Metformin Hydrochloride by Downstream Industry
4.2 Global Market Forecast of Metformin Hydrochloride by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Metformin Hydrochloride Market Status by Countries
  5.1.1 North America Metformin Hydrochloride Sales by Countries (2013-2017)
  5.1.2 North America Metformin Hydrochloride Revenue by Countries (2013-2017)
  5.1.3 United States Metformin Hydrochloride Market Status (2013-2017)
  5.1.4 Canada Metformin Hydrochloride Market Status (2013-2017)
  5.1.5 Mexico Metformin Hydrochloride Market Status (2013-2017)
5.2 North America Metformin Hydrochloride Market Status by Manufacturers
5.3 North America Metformin Hydrochloride Market Status by Type (2013-2017)
  5.3.1 North America Metformin Hydrochloride Sales by Type (2013-2017)
  5.3.2 North America Metformin Hydrochloride Revenue by Type (2013-2017)
5.4 North America Metformin Hydrochloride Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Metformin Hydrochloride Market Status by Countries
  6.1.1 Europe Metformin Hydrochloride Sales by Countries (2013-2017)
  6.1.2 Europe Metformin Hydrochloride Revenue by Countries (2013-2017)
  6.1.3 Germany Metformin Hydrochloride Market Status (2013-2017)
  6.1.4 UK Metformin Hydrochloride Market Status (2013-2017)
  6.1.5 France Metformin Hydrochloride Market Status (2013-2017)
  6.1.6 Italy Metformin Hydrochloride Market Status (2013-2017)
  6.1.7 Russia Metformin Hydrochloride Market Status (2013-2017)
  6.1.8 Spain Metformin Hydrochloride Market Status (2013-2017)
  6.1.9 Benelux Metformin Hydrochloride Market Status (2013-2017)
6.2 Europe Metformin Hydrochloride Market Status by Manufacturers
6.3 Europe Metformin Hydrochloride Market Status by Type (2013-2017)
  6.3.1 Europe Metformin Hydrochloride Sales by Type (2013-2017)
  6.3.2 Europe Metformin Hydrochloride Revenue by Type (2013-2017)
6.4 Europe Metformin Hydrochloride Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Metformin Hydrochloride Market Status by Countries
  7.1.1 Asia Pacific Metformin Hydrochloride Sales by Countries (2013-2017)
  7.1.2 Asia Pacific Metformin Hydrochloride Revenue by Countries (2013-2017)
  7.1.3 China Metformin Hydrochloride Market Status (2013-2017)
  7.1.4 Japan Metformin Hydrochloride Market Status (2013-2017)
  7.1.5 India Metformin Hydrochloride Market Status (2013-2017)
  7.1.6 Southeast Asia Metformin Hydrochloride Market Status (2013-2017)
  7.1.7 Australia Metformin Hydrochloride Market Status (2013-2017)
7.2 Asia Pacific Metformin Hydrochloride Market Status by Manufacturers
7.3 Asia Pacific Metformin Hydrochloride Market Status by Type (2013-2017)
  7.3.1 Asia Pacific Metformin Hydrochloride Sales by Type (2013-2017)
  7.3.2 Asia Pacific Metformin Hydrochloride Revenue by Type (2013-2017)
7.4 Asia Pacific Metformin Hydrochloride Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Metformin Hydrochloride Market Status by Countries
  8.1.1 Latin America Metformin Hydrochloride Sales by Countries (2013-2017)
  8.1.2 Latin America Metformin Hydrochloride Revenue by Countries (2013-2017)
  8.1.3 Brazil Metformin Hydrochloride Market Status (2013-2017)
  8.1.4 Argentina Metformin Hydrochloride Market Status (2013-2017)
  8.1.5 Colombia Metformin Hydrochloride Market Status (2013-2017)
8.2 Latin America Metformin Hydrochloride Market Status by Manufacturers
8.3 Latin America Metformin Hydrochloride Market Status by Type (2013-2017)
  8.3.1 Latin America Metformin Hydrochloride Sales by Type (2013-2017)
  8.3.2 Latin America Metformin Hydrochloride Revenue by Type (2013-2017)
8.4 Latin America Metformin Hydrochloride Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Metformin Hydrochloride Market Status by Countries
  9.1.1 Middle East and Africa Metformin Hydrochloride Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa Metformin Hydrochloride Revenue by Countries (2013-2017)
  9.1.3 Middle East Metformin Hydrochloride Market Status (2013-2017)
  9.1.4 Africa Metformin Hydrochloride Market Status (2013-2017)
9.2 Middle East and Africa Metformin Hydrochloride Market Status by Manufacturers
9.3 Middle East and Africa Metformin Hydrochloride Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa Metformin Hydrochloride Sales by Type (2013-2017)
  9.3.2 Middle East and Africa Metformin Hydrochloride Revenue by Type (2013-2017)
9.4 Middle East and Africa Metformin Hydrochloride Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF METFORMIN HYDROCHLORIDE

10.1 Global Economy Situation and Trend Overview
10.2 Metformin Hydrochloride Downstream Industry Situation and Trend Overview

CHAPTER 11 METFORMIN HYDROCHLORIDE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Metformin Hydrochloride by Major Manufacturers
11.2 Production Value of Metformin Hydrochloride by Major Manufacturers
11.3 Basic Information of Metformin Hydrochloride by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Metformin Hydrochloride Major Manufacturer
  11.3.2 Employees and Revenue Level of Metformin Hydrochloride Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 METFORMIN HYDROCHLORIDE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 Bristol-Mayers Squibb
  12.1.1 Company profile
  12.1.2 Representative Metformin Hydrochloride Product
  12.1.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Bristol-Mayers Squibb
12.2 Shouguang Fukang Pharmaceutical
  12.2.1 Company profile
  12.2.2 Representative Metformin Hydrochloride Product
  12.2.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Shouguang Fukang Pharmaceutical
12.3 Harman Finochem
  12.3.1 Company profile
  12.3.2 Representative Metformin Hydrochloride Product
  12.3.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Harman Finochem
12.4 Vistin Pharma
  12.4.1 Company profile
  12.4.2 Representative Metformin Hydrochloride Product
  12.4.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Vistin Pharma
12.5 CR Double-Crane
  12.5.1 Company profile
  12.5.2 Representative Metformin Hydrochloride Product
  12.5.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of CR Double-Crane
12.6 Keyuan Pharmaceutical
  12.6.1 Company profile
  12.6.2 Representative Metformin Hydrochloride Product
  12.6.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Keyuan Pharmaceutical
12.7 FARMHISPANIA GROUP
  12.7.1 Company profile
  12.7.2 Representative Metformin Hydrochloride Product
  12.7.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of FARMHISPANIA GROUP
12.8 Shijiazhuang Polee Pharmaceutical
  12.8.1 Company profile
  12.8.2 Representative Metformin Hydrochloride Product
  12.8.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Shijiazhuang Polee Pharmaceutical
12.9 Merck Sante
  12.9.1 Company profile
  12.9.2 Representative Metformin Hydrochloride Product
  12.9.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Merck Sante
12.10 Aarti Drugs
  12.10.1 Company profile
  12.10.2 Representative Metformin Hydrochloride Product
  12.10.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Aarti Drugs
12.11 TEVA
  12.11.1 Company profile
  12.11.2 Representative Metformin Hydrochloride Product
  12.11.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of TEVA
12.12 Taj API
  12.12.1 Company profile
  12.12.2 Representative Metformin Hydrochloride Product
  12.12.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Taj API
12.13 Wanbury
  12.13.1 Company profile
  12.13.2 Representative Metformin Hydrochloride Product
  12.13.3 Metformin Hydrochloride Sales, Revenue, Price and Gross Margin of Wanbury

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF METFORMIN HYDROCHLORIDE

13.1 Industry Chain of Metformin Hydrochloride
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF METFORMIN HYDROCHLORIDE

14.1 Cost Structure Analysis of Metformin Hydrochloride
14.2 Raw Materials Cost Analysis of Metformin Hydrochloride
14.3 Labor Cost Analysis of Metformin Hydrochloride
14.4 Manufacturing Expenses Analysis of Metformin Hydrochloride

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications